PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis

Conclusions: This study suggests that PRMT4 may promote the progression of HCC cells by activating the AKT/mTOR signaling pathway, which may be a valuable biomarker and potential target for HCC.PMID:34522186 | PMC:PMC8436100 | DOI:10.7150/ijms.62467
Source: International Journal of Medical Sciences - Category: Biomedical Science Authors: Source Type: research